Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
Gross Profit
Adaptive Biotechnologies Corp
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Gross Profit
$94.7m
|
CAGR 3-Years
8%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Gross Profit
$17.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
|
Danaher Corp
NYSE:DHR
|
Gross Profit
$25.6B
|
CAGR 3-Years
21%
|
CAGR 5-Years
23%
|
CAGR 10-Years
10%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Gross Profit
$2.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Agilent Technologies Inc
NYSE:A
|
Gross Profit
$3.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Gross Profit
$5.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
7%
|
CAGR 10-Years
15%
|
See Also
What is Adaptive Biotechnologies Corp's Gross Profit?
Gross Profit
94.7m
USD
Based on the financial report for Dec 31, 2023, Adaptive Biotechnologies Corp's Gross Profit amounts to 94.7m USD.
What is Adaptive Biotechnologies Corp's Gross Profit growth rate?
Gross Profit CAGR 5Y
21%
Over the last year, the Gross Profit growth was -26%. The average annual Gross Profit growth rates for Adaptive Biotechnologies Corp have been 8% over the past three years , 21% over the past five years .